Does Operable Stage IV Gingivobuccal Cancers Need Further Prognostic Subgrouping?
Autor: | Shubhada Khanapure, Smruti Mokal, Azmat Doctor, Sultan Pradhan, Rajan Kannan, Saurabh Jain |
---|---|
Rok vydání: | 2020 |
Předmět: |
Oncology
medicine.medical_specialty Multivariate analysis business.industry Cancer Disease medicine.disease 03 medical and health sciences 0302 clinical medicine Otorhinolaryngology Median follow-up 030220 oncology & carcinogenesis Internal medicine medicine Surgery Observational study Stage (cooking) 030223 otorhinolaryngology Stage iv business |
Zdroj: | Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India. 74(Suppl 2) |
ISSN: | 2231-3796 |
Popis: | Operable stage IV gingivobuccal complex cancer is classified as Stage IVA and IVB. Among patients with Stage IVA disease, different subgroups with likely different prognoses are combined. Patients with advanced nodal status tend to have a poorer prognosis. We divided these patients into four groups: group I (T4aN0), group II (T4aN1-2), group III (T1-3N2) constituting stage IVA category, and group IV (TanyN3) representing stage IVB. This study assesses if these patients can be prognostically subgrouped based on nodal status. It is a prospective observational study done at a tertiary care center from July 2017 to June 2020. This study aims to analyze survival outcomes in these subgroups using Kaplan Meir, univariate and multivariate analysis. The study enrolled 113 patients of operable gingivobuccal complex stage IVA cancer with a median follow up of 26 months, disease-free survival (DFS) was 74% for group 1, while it was 55%, 26% and 32.2% for group 2, group 3 and group 4 respectively. Patients with T4N3 disease had DFS of just 15%. Patients in group 3 and 4 had the worst outcomes in terms of DFS and Overall Survival(OS) with HR-3.7 and 3.3 and 3.3 and 3.8 respectively (p value-0.001). The nodal status is the most important prognostic factor affecting DFS and OS. Patients with small primary but advanced nodal stage do poorly than patients with advanced primary and node-negative disease. There is a need for subgrouping patients with Stage IVA tumors based on nodal status for better prognostication. |
Databáze: | OpenAIRE |
Externí odkaz: |